Neoplasie della mammella
Anno: 2006
-
Riferimento:Cancer Causes Control. 2006 May;17(4):375-83.Azione della melatonina:Nocturnal rodents are frequently used as models in C human breast cancer research, the circadian systems of nocturnal rodents are approximately 10,000 times moresensitive toopticalradiation than that ofhumans.Target:Circadian disruption and breast cancer.
-
Titolo: Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot studyRiferimento:Oncol Nurs Forum. 2006 Jul 1;33(4):775-83.Azione della melatonina:Fatigue, sleep, and depressive symptoms are more prevalent in women with cancer than a cancer-free comparison group.Target:Wrist, Sleep, Actigraphy.
-
Riferimento:Cancer Res. 2006 Apr 1;66(7):3954; author reply 3954.Azione della melatonina:No abstract available.Target:No abstract available.
-
Riferimento:Neuro Endocrinol Lett. 2006 Jun;27(3):351-4.Azione della melatonina:The effects of MLT and CGP 52 608 (the selective ligand for nuclear RZR/ROR receptors) were comparable with suppression caused by methotrexate.Target:CGP 52608
-
Titolo: It's Erren's brainchild, folks!Riferimento:Cancer Res. 2006 Apr 1;66(7):3954-5.Azione della melatonina:No abstract available.Target:No abstract available.
-
Riferimento:J Natl Cancer Inst. 2006 Jun 21;98(12):806-7.Azione della melatonina:No abstract available.Target:No abstract available.
-
Riferimento:Cancer Invest. 2006 Mar;24(2):149-53.Azione della melatonina:RAS in pineal gland is modified in rats with breast cancer induced by NMU (N-methyl nitrosourea) through the inhibition of AspAP (Aspartyl aminopeptidase) activity, which may lead to increased levels of Ang II (angiotensin II).Target:Renin-angiotensin-system (RAS)
-
Riferimento:Cancer Res. 2006 May 15;66(10):5521-5.Azione della melatonina:A link between low levels of melatonin and increased risk of breast cancer has been suggested but we found no convincing evidence for an association between sleep duration and incidence of breast cancer.Target:Habitual sleep duration.
Anno: 2007
-
Riferimento:Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2509-12.Azione della melatonina:In premenopausal women, the urinary aMT6-s level was significantly positively associated with percent mammographic density. No evidence that the melatonin level is inversely associated with mammographic density.Target:(aMT6-s). 6-sulfatoxymelatonin
-
Riferimento:Epidemiology. 2007 Mar;18(2):266-9.Azione della melatonina:Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the nocturnal production of melatonin.Breast cancer risk was not associated with exposure to residential magnetic fields, regardless of medication use.Target:Magnetic fields.